BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, EGFR, cell-cell adhesion, Allergy to pollen, Hippocampus, Laryngoscope)
Bookmark Forward

Novel therapeutic strategies for recurrent SCLC.

Laura Moliner, Bingnan Zhang, Giuseppe Lamberti, Andrea Ardizzoni, Lauren A Byers, Raffaele Califano

Critical reviews in oncology/hematology 2023 Jun


filter terms:
  • humans (1)
  • lung (1)
  • lung neoplasms (1)
  • outcomes treatment (1)
  • patients (2)
  • prognosis (2)
  • SCLC (2)
    • Sizes of these terms reflect their relevance to your search.

    Therapeutic options for patients with relapsed SCLC are limited, and the prognosis in this setting remains poor. While clinical outcomes for frontline treatment have modestly improved with the introduction of immunotherapy, treatment in the second-line setting persists almost unchanged. In this review, current treatment options and recent advances in molecular biology are described. Emerging therapeutic options in this setting, and potential strategies to improve clinical outcomes of these patients are also addressed. Copyright © 2023 Elsevier B.V. All rights reserved.

    Citation

    Laura Moliner, Bingnan Zhang, Giuseppe Lamberti, Andrea Ardizzoni, Lauren A Byers, Raffaele Califano. Novel therapeutic strategies for recurrent SCLC. Critical reviews in oncology/hematology. 2023 Jun;186:104017

    Expand section icon Mesh Tags


    PMID: 37150311

    View Full Text
    • Copyright © 2024 Illumina Inc. All rights reserved.